C
54
3
DVN
31
4
BIIB
40
2
AEE
76
3
AON
56
-6
PNC
52
2
OMC
35
4
HAL
48
5
ADM
42
5
BAX
39
4
KIM
69
5
PPG
40
5
M
17
3
JPM
59
4
HON
52
3
PSA
55
4
HOG
40
2
MHK
48
3
FIS
78
16
PEG
57
4
C
54
3
DVN
31
4
BIIB
40
2
AEE
76
3
AON
56
-6
PNC
52
2
OMC
35
4
HAL
48
5
ADM
42
5
BAX
39
4
KIM
69
5
PPG
40
5
M
17
3
JPM
59
4
HON
52
3
PSA
55
4
HOG
40
2
MHK
48
3
FIS
78
16
PEG
57
4
Financhill
Back

INmune Bio Stock Predictions

Top investors are buying this "unlisted" stock

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
33

INMB
INmune Bio

Last Price:
$7.30
Seasonality Move:
31.04%

7 Day Trial

ALL ACCESS PASS

$ 7

This tech company grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

INmune Bio Stock Forecast

  • Over the next 52 weeks, INmune Bio has on average historically risen by 27% based on the past 6 years of stock performance.
  • INmune Bio has risen higher in 2 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
  • Is INmune Bio Stock Undervalued?
    The current INmune Bio [INMB] share price is $7.32. The Score for INMB is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • INMB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will INmune Bio Stock Go Up Next Year?

  • Over the next 52 weeks, INmune Bio has on average historically risen by 27% based on the past 6 years of stock performance.

INmune Bio Stock Rating

Sell
33
INmune Bio (INMB) is a Sell

Is INmune Bio overpriced?

  • INmune Bio has risen higher in 2 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

INmune Bio Stock Price History

Is INMB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INMB is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
inmunebio.com

52-Week Data

52-Week High:
12.72
52-Week Low:
4.32

Prediction Charts

Market Cap:
167.8M
Price in USD:
7.32
Volume:
174.7K
Beta:
1.89

Technical Analysis

SMA50:
8.16
SMA100:
6.97
SMA200:
6.79
52-Wk Change:
-13.17%

Stock Predictions

  • Is INmune Bio stock public?
    Yes, INmune Bio is a publicly traded company.
  • What is the INmune Bio stock quote today?
    The INmune Bio stock price is 7.32 USD today.
  • How to buy INmune Bio stock online?
    You can buy INmune Bio shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-31 7.46 7.81 7.81 7.29
Apr-1 7.78 7.59 7.95 7.33
Apr-2 7.41 8.07 8.16 7.41
Apr-3 7.71 7.77 7.89 7.48
Apr-4 7.77 7.27 7.89 7.02
Apr-7 7.00 7.30 7.45 6.55
Apr-8 7.49 6.84 7.64 6.77
Apr-9 6.66 7.63 7.76 6.31
Apr-10 7.38 6.73 7.58 6.68
Apr-11 6.75 7.38 7.47 6.54
Apr-14 7.45 7.56 7.60 7.16
Apr-15 7.68 7.47 7.78 7.26
Apr-16 7.27 7.31 7.51 7.14
Apr-17 7.34 7.32 7.51 7.14

INmune Bio Earnings

INmune Bio Earnings Report: Per Share INmune Bio Earnings Q1 Q2 Q3 and Q4 last year and next year.

INmune Bio Forecast Revenue Growth

INmune Bio Stock Analysis: Historical quarterly revenues per share for INmune Bio and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.16 per share, an increase this year of $0.44 per share, and an increase next year of $0.09 per share.

* INmune Bio stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.